BRIDGEWATER, N.J., May 29, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to…Original Article
FDA Approves Zilxi (minocycline) Topical Foam for the Treatment of Rosacea
